Table 3.
T2DM (n = 69) | Prediabetes (n = 586) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Crude | Adjusted* | Crude | Adjusted* | |||||||
OR | 95% CI | OR | 95% CI | p‐Value** | OR | 95% CI | OR | 95% CI | p‐Value** | |
Advanced group | 2.4 | 1.4–4.2 | 2.2 | 1.2–4 | 0.01 | 2.3 | 1.8–2.9 | 1.9 | 1.5–2.4 | <.01 |
Mild increase group | 0.8 | 0.4–1.4 | 0.7 | 0.4–1.4 | .02 | 1.4 | 1.2–1.7 | 1.3 | 1.1–1.6 | <.01 |
Controls | 1 | – | 1 | – | – | 1 | 1 | – | – |
Note: Logistic regression models were used to estimate the OR and 95% CI, adjusted for age, sex and BMI‐SDS.
Abbreviations: OR, odds ratio; 95% CI, 95% confidence interval; BMI‐SDS, BMI as standard deviation score; OGTT, oral glucose tolerance test; T2DM, type 2 diabetes mellitus.
p‐Value: Difference in adjusted odds ratios for T2DM between different groups with elevated transaminases compared to control group.
p‐Value: Difference in adjusted odds ratios for prediabetes between different groups with elevated transaminases compared to control group.